RECORD // Company

Harvard Apparatus Regenerative Technology, Inc.

Formerly: Biostage, Inc.

Built 2026-11-22T03:19:04Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Records under a former name (1)

The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.

Matched by name only, not merged (1)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

5 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001437749-26-036714

ItemValuePeriodFormFiledAccessionReport
Revenue$145,0003 months ended 2026-09-3010-Q2026-11-130001437749-26-0367142026-11-22 03:19 UTCReport an error
Net income (loss)$-1,463,0003 months ended 2026-09-3010-Q2026-11-130001437749-26-0367142026-11-22 03:19 UTCReport an error
Interest expense$13,0003 months ended 2026-09-3010-Q2026-11-130001437749-26-0367142026-11-22 03:19 UTCReport an error
Cash and cash equivalents$1,851,000at 2026-09-3010-Q2026-11-130001437749-26-0367142026-11-22 03:19 UTCReport an error
Contract liabilities, current$690,000at 2026-09-3010-Q2026-11-130001437749-26-0367142026-11-22 03:19 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001563665
Ticker
HRGN
EIN
455210462
CUSIP
09074M202
Record ID
sx:sec:0001563665

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

25 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-13SEC EDGAR company profile2026-11-22 03:19 UTCReport an error
SIC industry3841 Surgical & Medical Instruments & Apparatus2026-11-13SEC EDGAR company profile2026-11-22 03:19 UTCReport an error
State of incorporationDE2026-11-13SEC EDGAR company profile2026-11-22 03:19 UTCReport an error
Fiscal year end (MMDD)12312026-11-13SEC EDGAR company profile2026-11-22 03:19 UTCReport an error
Business address84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 017462026-11-13SEC EDGAR company profile2026-11-22 03:19 UTCReport an error
ExchangesOTC2026-11-13SEC EDGAR company profile2026-11-22 03:19 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$704,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 03:19 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-6,869,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 03:19 UTCReport an error
Total assets (at 2025-12-31)$2,677,0002025-12-3110-K, XBRL Assets2026-11-22 03:19 UTCReport an error
Stockholders' equity (at 2025-12-31)$1,057,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 03:19 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$1,352,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 03:19 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-3,828,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 03:19 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2024-12-31)$02024-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 03:19 UTCReport an error
Operating lease liabilities (at 2025-12-31)$199,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 03:19 UTCReport an error
Form D total offering amount (D filed 2026-09-14)$3,000,0002026-09-14D2026-11-22 03:19 UTCReport an error
Form D total amount sold (D filed 2026-09-14)$2,838,9112026-09-14D2026-11-22 03:19 UTCReport an error
Form D industry groupBiotechnology2026-09-14D2026-11-22 03:19 UTCReport an error
Form D revenue rangeDecline to Disclose2026-09-14D2026-11-22 03:19 UTCReport an error
Form D date of first sale2026-09-112026-09-14D2026-11-22 03:19 UTCReport an error
8-K Item 1.01 (filed 2026-09-14)Entry Into a Material Definitive Agreement. On September 11, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into Securities Purchase Agreements (each a “Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the Investors agreed to purchase in a private placement an aggregate of 2,703,727 shares of common stock for an aggregate purchase price of $2,838,911 and a purchase price per share of $1.05 (the “Private Placement”). The Private Placement closed on September 11, 2026. Included in the Private Placement, Jerry (Junli) He, the Company’s Chief Executive Officer, purchased 683,725 shares of common stock in exchange for the conversion…2026-09-14SEC EDGAR 8-K 0001437749-26-030244 (text as filed, excerpt)2026-11-22 03:19 UTCReport an error
8-K Item 3.02 (filed 2026-09-14)Unregistered Sale of Equity Securities. The information contained above in Item 1.01 related to the Private Placement is hereby incorporated by reference into this Item 3.02. The shares of common stock issued to the Investors were sold and issued without registration under the Securities Act in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as transactions not involving a public offering and Rule 506 promulgated under the Securities Act as sales to accredited investors, and in reliance on similar exemptions under applicable state laws.2026-09-14SEC EDGAR 8-K 0001437749-26-030244 (text as filed, excerpt)2026-11-22 03:19 UTCReport an error
8-K Item 1.01 (filed 2026-08-03)Entry into a Material Definitive Agreement. May 2026 Bridge Note On May 8, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into a loan arrangement with Junli He, the Chairman and Chief Executive Officer of the Company (the “Lender”), pursuant to which the Lender agreed to loan the Company an aggregate amount of $200,000 as evidenced by a Bridge Note executed by the Company in favor of, and accepted by, the Lender (the “May Bridge Note”). The May Bridge Note accrues interest at an annual fixed rate of 8%, calculated on the basis of the actual number of days elapsed in a 360-day year, and the principal amount thereof will be due and payable in full, together with…2026-08-03SEC EDGAR 8-K 0001437749-26-025423 (text as filed, excerpt)2026-11-22 03:19 UTCReport an error
8-K Item 2.03 (filed 2026-08-03)Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 of this Current Report on Form 8-K with respect to the May Bridge Note and the July Bridge Note is incorporated by reference into this Item 2.03.2026-08-03SEC EDGAR 8-K 0001437749-26-025423 (text as filed, excerpt)2026-11-22 03:19 UTCReport an error
8-K Item 1.01 (filed 2026-08-03)Entry into a Material Definitive Agreement. On April 13, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into a loan arrangement with Junli He, the Chairman and Chief Executive Officer of the Company (the “Lender”), pursuant to which the Lender agreed to loan the Company an aggregate amount of $300,000 as evidenced by a Bridge Note executed by the Company in favor of, and accepted by, the Lender (the “Bridge Note”). The Bridge Note accrued interest at an annual fixed rate of 8%, and the principal amount thereof will be due and payable in full, together with all accrued and unpaid interest thereon, on the earlier to occur of a) the closing date (or later date of…2026-08-03SEC EDGAR 8-K 0001437749-26-025419 (text as filed, excerpt)2026-11-22 03:19 UTCReport an error
8-K Item 2.03 (filed 2026-08-03)Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 of this Current Report on Form 8-K/A with respect to the Bridge Note is incorporated by reference into this Item 2.03.2026-08-03SEC EDGAR 8-K 0001437749-26-025419 (text as filed, excerpt)2026-11-22 03:19 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.